GlassScriptPhysician profile
Amanda Gail Johnson
NPI 1245837715
$15,839.87
in general payments reported to CMS, 2019-2025
43 companies · $3,549 in 2025
The $3,549 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,397 · 2022: $2,661 · 2023: $3,364 · 2024: $3,869 · 2025: $3,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $77.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,704.08 |
| Education | $77.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,125.99 | 2021-2025 | Enbrel, Evenity, Otezla |
| Abbvie INC. | $2,646.87 | 2021-2025 | |
| Ucb, INC. | $1,441.81 | 2021-2025 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $1,329.69 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Astrazeneca Pharmaceuticals LP | $943.54 | 2021-2025 | Saphnelo |
| Mallinckrodt Hospital Products INC. | $831.44 | 2021-2025 | Acthar |
| Pfizer INC. | $827.08 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $766.85 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $727.49 | 2022-2025 | Purified Cortrophin Gel |
| Aurinia Pharma U.S., INC. | $726.20 | 2021-2025 | Lupkynis |
| Lilly USA, LLC | $482.74 | 2021-2024 | Taltz |
| Glaxosmithkline, LLC. | $321.82 | 2021-2025 | Benlysta |
| Alexion Pharmaceuticals, INC. | $239.86 | 2022-2025 | Strensiq |
| Radius Health, INC. | $227.22 | 2021-2024 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $154.09 | 2024-2025 | Orencia |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.